← back to search

Paul H. M. Savelkoul

Department of Health · NL
Area of research
Molecular Biology · Infectious Diseases
Research interest
Research interests include Gut microbiota and health, Bacterial Identification and Susceptibility Testing, Clostridium difficile and Clostridium perfringens research, and Antibiotic Resistance in Bacteria.
h-index
44
citations
5,845
works
172
NIH funding
primary concept
Medicine
email

Recent publications

Discovery of similar multidrug resistance regions in nosocomial Enterobacteriaceae outbreaks in three hospitals in the Netherlands.
2026cited by 0position: contributordoi
From food to vesicle: nutritional influences on gut microbial inflammatory signaling.
2026cited by 0position: contributordoi
Gut-derived bacterial membrane vesicles in prediabetes: Vesicle composition dictates inflammatory properties.
2026cited by 0position: contributordoi
Comparison of microbiota profiles of fecal samples, rectal swabs and mucosal biopsies in patients with inflammatory bowel disease.
2026cited by 0position: contributordoi
Earlier de-isolation of SARS-CoV-2-infected ICU patients using a novel viability PCR: a prospective cohort study.
2026cited by 0position: contributordoi
Prolonged incubation time unwarranted for acute periprosthetic joint infections.
2025cited by 5position: contributordoi
Enhancing <i>Acanthamoeba</i> diagnostics: rapid detection of viable <i>Acanthamoeba</i> trophozoites and cysts using viability PCR assay.
2025cited by 3position: contributordoi
A Novel Untargeted Molecular Detection Technique for Rapid Fecal Microbiota Profiling in Very Preterm Infants: Optimization, Genus-Level Comparison, and Application.
2025cited by 2position: contributordoi
Comparing visual and automated urine dipstick analysis in a general practice population.
2025cited by 2position: contributordoi
Assessment of the reproducibility of bacterial membrane vesicle isolation and characterization
Extracellular Vesicles and Circulating Nucleic Acids 2025cited by 1position: contributordoi
Silver multilayer coating on orthopedic implant material of different alloys and surfaces significantly reduces bacterial colonization.
2025cited by 0position: contributordoi
Lyophilized vancomycin-hydrochloride for intravenous use retains full bactericidal activity and molecular stability 20 years postexpiration.
2025cited by 0position: contributordoi
Nucleocapsid-directed antibody testing is unsuitable to estimate hybrid immunity against SARS-CoV-2, a longitudinal cross-border study in the Meuse-Rhine Euroregion.
2025cited by 0position: contributordoi
Gut-bacteria derived membrane vesicles and host metabolic health: a narrative review.
2024cited by 12position: contributordoi
Advancing COVID-19 diagnostics: rapid detection of intact SARS-CoV-2 using viability RT-PCR assay.
2024cited by 8position: contributordoi
Vaginal microbiota and spontaneous preterm birth in pregnant women at high risk of recurrence.
2024cited by 7position: contributordoi
Evaluation of microbial occurrence in reusable robotic instruments for minimally invasive surgery: A pilot study.
2024cited by 4position: contributordoi
Higher <i>Neisseria gonorrhoeae</i> bacterial load in coinfections with <i>Chlamydia trachomatis</i> compared with <i>Neisseria gonorrhoeae</i> single infections does not lead to more symptoms.
2024cited by 4position: contributordoi
The interrelation between microbial immunoglobulin coating, vaginal microbiota, ethnicity, and preterm birth.
2024cited by 3position: contributordoi
Cross-border mobility in the Meuse-Rhine Euroregion: impact of COVID-19 border restrictions on everyday activities and visiting social network members.
2024cited by 2position: contributordoi
One Health surveillance of colistin-resistant Enterobacterales in Belgium and the Netherlands between 2017 and 2019.
2024cited by 2position: contributordoi
Investigating the Immunomodulatory Impact of Fecal Bacterial Membrane Vesicles and Their IgA Coating Patterns in Crohn's Disease Patients.
2024cited by 1position: contributordoi
Clinical Applicability of Microbiota Sampling in a Subfertile Population: Urine versus Vagina.
2024cited by 1position: contributordoi
SARS-CoV-2 cellular and humoral responses in vaccine-naive individuals during the first two waves of COVID-19 infections in the southern region of The Netherlands: a cross-sectional population-based study.
2024cited by 1position: contributordoi
Impact of a large-scale event on SARS-CoV-2 cases and hospitalizations in the Netherlands, carnival seasons 2022 and 2023.
2024cited by 0position: contributordoi
Analysis of two sequential SARS-CoV-2 outbreaks on a haematology-oncology ward and the role of infection prevention.
2024cited by 0position: contributordoi
Elevated risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variants compared with Alpha variant in vaccinated individuals.
2023cited by 33position: contributordoi
Application of the Rome severity classification of COPD exacerbations in a real-world cohort of hospitalised patients.
2023cited by 14position: contributordoi
Rapid Diagnostics of Joint Infections Using IS-Pro.
2023cited by 8position: contributordoi
Corneal Transplantation for Infectious Keratitis: A Prospective Dutch Registry Study.
2023cited by 7position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Christian J. P. A. Hoebe · National Centre for Infectious Diseases17 papers (2020–2025)John Penders · UCLouvain15 papers (2019–2024) · 8 papers (2020–2026)Mathias W. Hornef · Friedrich Schiller University Jena5 papers (2020–2020)Frank Stassen · Maastricht University5 papers (2019–2025)Gernot Rohde · Ophthalmology Clinic3 papers (2017–2019)John W. A. Rossen · University Medical Center Groningen2 papers (2019–2021)Martin von Bergen� · Helmholtz Centre for Environmental Research2 papers (2020–2020)André Bleich · RELX Group (United States)2 papers (2020–2020)A. E. Budding · Leiden University2 papers (2025–2026)Johan Jocken · Maastricht University Medical Centre2 papers (2024–2025)Jari Verbunt · Maastricht University Medical Centre2 papers (2024–2025)Ellen E. Blaak · Institut des Maladies Métaboliques et Cardiovasculaires2 papers (2024–2025)Jesper M J Smeenk · Vrije Universiteit Amsterdam2 papers (2019–2019)Petra F. G. Wolffs · Maastricht University Medical Centre2 papers (2024–2026)Frank van Rosmalen · Maastricht Universitair Medisch Centrum+2 papers (2020–2026)Casper Jamin · Maastricht University Medical Centre2 papers (2021–2023)Jordy P.M. Coolen · Radboud University Nijmegen2 papers (2021–2022)Bas C T van Bussel · University Medical Center2 papers (2020–2026) · 2 papers (2024–2024)